Your browser doesn't support javascript.
loading
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
Smits, Bas; Goldacker, Sigune; Seneviratne, Suranjith; Malphettes, Marion; Longhurst, Hilary; Mohamed, Omar E; Witt-Rautenberg, Carla; Leeman, Lucy; Schwaneck, Eva; Raymond, Isabelle; Meghit, Kilifa; Uhlmann, Annette; Winterhalter, Christine; van Montfrans, Joris; Klima, Marion; Workman, Sarita; Fieschi, Claire; Lorenzo, Lorena; Boyle, Sonja; Onyango-Odera, Shamin; Price, Suzanne; Schmalzing, Marc; Aurillac, Valerie; Prasse, Antje; Hartmann, Ieneke; Meerburg, Jennifer J; Kemner-van de Corput, Mariette; Tiddens, Harm; Grimbacher, Bodo; Kelleher, Peter; Patel, Smita Y; Korganow, Anne-Sophie; Viallard, Jean-Francois; Tony, Hans-Peter; Bethune, Claire; Schulze-Koops, Hendrik; Witte, Torsten; Huissoon, Aarnoud; Baxendale, Helen; Grigoriadou, Sofia; Oksenhendler, Eric; Burns, Siobhan O; Warnatz, Klaus.
Affiliation
  • Smits B; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Goldacker S; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Frei
  • Seneviratne S; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom.
  • Malphettes M; Département d'Immunologie, Hôpital Saint-Louis, Paris, France.
  • Longhurst H; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom.
  • Mohamed OE; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
  • Witt-Rautenberg C; Division of Rheumatology and Clinical Immunology, Department of Medicine IV, University of Munich, Munich, Germany.
  • Leeman L; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom.
  • Schwaneck E; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany; Rheumatology/Clinical Immunology Asklepios Klinik Altona, Hamburg, Germany.
  • Raymond I; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France.
  • Meghit K; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France.
  • Uhlmann A; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinical Trials Unit, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Winterhalter C; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinical Trials Unit, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • van Montfrans J; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Klima M; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Frei
  • Workman S; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom.
  • Fieschi C; Département d'Immunologie, Hôpital Saint-Louis, Paris, France.
  • Lorenzo L; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom.
  • Boyle S; Clinical Immunology, Royal Papworth Hospital, Cambridge, United Kingdom.
  • Onyango-Odera S; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
  • Price S; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom.
  • Schmalzing M; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany.
  • Aurillac V; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France.
  • Prasse A; Department of Respiratory Medicine, Medizinische Hochschule Hannover, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease, Deutsches Zentrum für Lungenforschung, Hannover, Germany.
  • Hartmann I; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Meerburg JJ; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Kemner-van de Corput M; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Tiddens H; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Grimbacher B; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Frei
  • Kelleher P; Department of Infectious Diseases, Imperial College London, London, United Kingdom.
  • Patel SY; Department of Clinical Immunology, Oxford University Hospitals National Health Service Foundation Trust, United Kingdom; National Institute for Health and Care Research Biomedical Research Unit, University of Oxford, United Kingdom.
  • Korganow AS; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France.
  • Viallard JF; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France.
  • Tony HP; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany.
  • Bethune C; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom.
  • Schulze-Koops H; Rheumatology/Clinical Immunology Asklepios Klinik Altona, Hamburg, Germany.
  • Witte T; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Huissoon A; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
  • Baxendale H; Clinical Immunology, Royal Papworth Hospital, Cambridge, United Kingdom.
  • Grigoriadou S; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom.
  • Oksenhendler E; Département d'Immunologie, Hôpital Saint-Louis, Paris, France; Department of Clinical Immunology and Université de Paris, Paris, France.
  • Burns SO; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Warnatz K; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Frei
J Allergy Clin Immunol ; 152(2): 528-537, 2023 08.
Article in En | MEDLINE | ID: mdl-36587851
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Diseases, Interstitial Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Diseases, Interstitial Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Document type: Article Affiliation country: Country of publication: